ORGANOGENESIS HOLDINGS INC. Revenue, Net (Deprecated 2018-01-31)
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Revenue, Net (Deprecated 2018-01-31) of $0 for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Income Statement
us-gaap:SalesRevenueNet · last filed 2018-11-09
- ORGANOGENESIS HOLDINGS INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2018-09-30 was $0.00.
- ORGANOGENESIS HOLDINGS INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2018-06-30 was $0.00.
- ORGANOGENESIS HOLDINGS INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $0.00.
- ORGANOGENESIS HOLDINGS INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $0.00.
- ORGANOGENESIS HOLDINGS INC. revenue, net (deprecated 2018-01-31) for fiscal 2017 was $0.00.
- ORGANOGENESIS HOLDINGS INC. revenue, net (deprecated 2018-01-31) for fiscal 2016 was $0.00.
| Period end | Revenue, Net (Deprecated 2018-01-31) 3 month | Revenue, Net (Deprecated 2018-01-31) 6 month | Revenue, Net (Deprecated 2018-01-31) 9 month | Revenue, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $0.00 derived: sum of 2 quarters · filed 2018-11-09 | $0.00 10-Q · filed 2018-11-09 | $0.00 derived: sum of 4 quarters · filed 2018-11-09 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $0.00 10-Q · filed 2018-08-07 | $0.00 derived: sum of 3 quarters · filed 2018-08-07 | $0.00 derived: sum of 4 quarters · filed 2018-08-07 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-10 | $0.00 derived: sum of 2 quarters · filed 2018-05-10 | $0.00 derived: sum of 3 quarters · filed 2018-05-10 | $0.00 derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $0.00 derived: sum of 2 quarters · filed 2018-03-14 | $0.00 derived: sum of 3 quarters · filed 2018-03-14 | $0.00 10-K · filed 2018-03-14 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $0.00 derived: sum of 2 quarters · filed 2017-11-14 | $0.00 10-Q · filed 2017-11-14 | $0.00 derived: sum of 4 quarters · filed 2017-11-14 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $0.00 10-Q · filed 2017-08-11 | $0.00 derived: sum of 3 quarters · filed 2017-08-11 | |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-12 | $0.00 derived: sum of 2 quarters · filed 2017-05-12 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-28 | $0.00 10-K · filed 2017-03-28 | ||
| 2016-09-30 | $0.00 10-Q · filed 2016-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |